ALLMedicine™ Pituitary Macroadenomas Center
Research & Reviews 297 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465851
The British Journal of Radiology; Conficoni A, Feraco P et. al.
Jul 6th, 2020 - Pituitary macroadenomas (PAs) are usually defined as benign intracranial tumors. However, they may present local aggressive course. High Ki67 labelling index (LI) values have been related to an aggressive tumor behavior. A recent clinicopathologic...
https://doi.org/10.1016/j.ejrad.2020.109125
European Journal of Radiology; Liu YQ, Gao BB et. al.
Jun 27th, 2020 - To assess the vascular heterogeneity and aggressiveness of pituitary macroadenomas (PM) using texture analysis based on Dynamic Contrast-Enhanced MRI (DCE-MRI). Fifty patients with pathologically confirmed PM, including 32 patients with aggressive...
https://doi.org/10.1016/j.wneu.2020.06.086
World Neurosurgery; Avraham E, Azriel A et. al.
Jun 20th, 2020 - Visual status is routinely evaluated by neuro-ophthalmologic examination and computerized visual field (VF) tests in patients with chiasmal compression secondary to pituitary macroadenoma. Currently, no relevant data exists to accurately quantify ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301455
BMC Cancer; Ding L, Zhang F et. al.
Jun 19th, 2020 - Differentiation of suprasellar meningiomas (SSMs) from non-functioning pituitary macroadenomas (NFPMAs) is useful for clinical management. We investigated the utility of 13N-ammonia combined with 18F-FDG positron emission tomography (PET)/computed...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316692
Pituitary Pelsma ICM, Verstegen MJT et. al.
May 18th, 2020 - Surgery in patients with non-functioning pituitary macroadenomas (NFMA) is effective in ameliorating visual function. The urgency for decompression, and preferred timing of surgery related to the preoperative severity of dysfunction is unknown. Sy...
Clinicaltrials.gov 297 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465851
The British Journal of Radiology; Conficoni A, Feraco P et. al.
Jul 6th, 2020 - Pituitary macroadenomas (PAs) are usually defined as benign intracranial tumors. However, they may present local aggressive course. High Ki67 labelling index (LI) values have been related to an aggressive tumor behavior. A recent clinicopathologic...
https://doi.org/10.1016/j.ejrad.2020.109125
European Journal of Radiology; Liu YQ, Gao BB et. al.
Jun 27th, 2020 - To assess the vascular heterogeneity and aggressiveness of pituitary macroadenomas (PM) using texture analysis based on Dynamic Contrast-Enhanced MRI (DCE-MRI). Fifty patients with pathologically confirmed PM, including 32 patients with aggressive...
https://doi.org/10.1016/j.wneu.2020.06.086
World Neurosurgery; Avraham E, Azriel A et. al.
Jun 20th, 2020 - Visual status is routinely evaluated by neuro-ophthalmologic examination and computerized visual field (VF) tests in patients with chiasmal compression secondary to pituitary macroadenoma. Currently, no relevant data exists to accurately quantify ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301455
BMC Cancer; Ding L, Zhang F et. al.
Jun 19th, 2020 - Differentiation of suprasellar meningiomas (SSMs) from non-functioning pituitary macroadenomas (NFPMAs) is useful for clinical management. We investigated the utility of 13N-ammonia combined with 18F-FDG positron emission tomography (PET)/computed...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316692
Pituitary Pelsma ICM, Verstegen MJT et. al.
May 18th, 2020 - Surgery in patients with non-functioning pituitary macroadenomas (NFMA) is effective in ameliorating visual function. The urgency for decompression, and preferred timing of surgery related to the preoperative severity of dysfunction is unknown. Sy...
